Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Westphal Christoph H
Relationship:   10% Owner
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   6,222,903    

Indirect Shares

   9,212,891      
Direct Value   $5,876,236    

Indirect Value

   $370,354,860      
Total Shares   15,435,794      
Total Value   $376,231,096      


Verastem, Inc. $2,740,723 Tempest Therapeutics, Inc $744,043 Salarius Pharmaceuticals, Inc $2,391,470 Tscan Therapeutics, Inc. $0 Verastem, Inc. $2,740,723 Tempest Therapeutics, Inc $744,043 Salarius Pharmaceuticals, Inc $2,391,470 Tscan Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Momenta Pharmaceuticals Inc MNTA Director 2004-06-25 0 2004-06-25 76,648    Premium*  
            Alnylam Pharmaceuticals Inc ALNY Director, 10% Owner 2004-05-27 0 2004-06-03 2,409,970    Premium*  
            Verastem, Inc. VSTM Executive Chairman, Di... 2015-06-30 665,224 2015-06-30 1,500,063    Premium*  
            Tempest Therapeutics, Inc TPST Director, 10% Owner 2014-03-07 701,927 2014-03-07 3,825,421    Premium*  
            Salarius Pharmaceuticals, Inc SLRX 10% Owner 2018-10-16 3,941,118 2018-10-16 0    Premium*  
            Tscan Therapeutics, Inc. TCRX 10% Owner 2021-07-20 914,634 2021-07-20 1,400,789    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
VSTM Verastem, Inc. Executive Chairman   •       •      –    2015-01-28 4 B $6.50 $7,999,999 I/I 1,230,769 1,230,769 2.66 -
VSTM Verastem, Inc. President and CEO   •       •       •   2012-02-01 4 A $10.00 $6,000,000 I/I 600,000 2,869,841 0 -
SLRX Salarius Pharmaceuticals,... 10% Owner   –       –       •   2018-10-16 4 S $0.92 $2,941,053 I/I (3,212,861) 0 0 -
TCRX Tscan Therapeutics, Inc. 10% Owner   –       –       •   2021-07-20 4 B $15.00 $1,999,995 I/I 133,333 1,278,838 1.5 -
ALNY Alnylam Pharmaceuticals I... Director   –       •       •   2004-05-27 4 B $6.00 $1,875,000 I/I 312,500 300,170 2.25 -
MNTA Momenta Pharmaceuticals I... Director   –       •      –    2004-06-25 4 B $6.50 $1,040,000 I/I 160,000 76,648 2.1 -
TPST Tempest Therapeutics, Inc Director   –       •       •   2014-03-07 4 B $10.00 $1,000,000 I/I 100,000 3,820,571 2.25 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-03-11 4 B $7.00 $627,760 I/I 89,680 2,786,944 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-03-21 4 B $11.70 $564,195 I/I 48,058 2,910,955 2.64 -
VSTM Verastem, Inc. Chief Executive Officer   •       •       •   2013-03-12 4 D $9.37 $345,416 D/D (36,864) 703,731 0 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-03-23 4 B $11.55 $292,862 I/I 25,356 2,936,311 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-03-22 4/A B $11.78 $282,143 I/I 23,951 2,910,955 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-03-24 4 B $10.55 $255,384 I/I 24,207 2,960,518 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-27 4 B $12.68 $219,364 I/I 17,300 3,153,861 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-24 4 B $12.50 $212,088 I/I 16,967 3,107,961 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-03-17 4 B $10.94 $209,359 I/I 19,137 2,844,460 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-03-16 4 B $10.85 $207,691 I/I 19,142 2,825,323 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-26 4 B $12.53 $204,239 I/I 16,300 3,136,561 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-03-18 4 B $11.06 $203,913 I/I 18,437 2,862,897 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-17 4 B $11.14 $202,748 I/I 18,200 3,054,513 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-03-15 4 B $9.62 $185,060 I/I 19,237 2,806,181 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-09 4 B $9.80 $171,814 I/I 17,532 2,978,050 2.64 -
VSTM Verastem, Inc. Director   –       •       •   2014-01-08 4 D $13.59 $168,407 D/D (12,392) 703,814 0 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-18 4 B $11.05 $167,960 I/I 15,200 3,069,713 2.64 -
SLRX Salarius Pharmaceuticals,... President and CEO   •       •       •   2016-05-23 4 B $12.31 $164,548 I/I 13,367 3,090,994 2.64 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us